HUM Stock Recent News
HUM LATEST HEADLINES
The medical sector giant was one of the first carriers to sound the alarm of rising inpatient utilization costs, notably with its Medicare Advantage (MA) plan members in Q4 2023.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25, 2025 to stockholders of record as of the close of business on March 28, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Monogram Health announce expansion of comprehensive kidney care program.
Humana Inc.'s Q4 and full-year 2024 earnings report shows a 10% revenue increase but significant losses, highlighting major structural issues in its business model. Rising healthcare utilization and insufficient CMS rate increases have severely impacted Humana's profitability, with shares down 50% from their 2023 peak. New management aims to improve efficiency and service quality, but the company's future hinges on CMS rate decisions and star-rating litigation outcomes.
The cuts will mean turmoil and confusion for many beneficiaries, as well as the risk of higher premiums, fewer benefits or both.
HUM's fourth-quarter results suffer a blow due to a membership decline in Medicare stand-alone PDP, partly offset by a strong Primary Care business. It currently expects 2025 adjusted EPS to be around $16.25.
Humana, Inc. (NYSE:HUM ) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO George Renaudin - President, Insurance Conference Call Participants Ann Hynes - Mizuho Justin Lake - Wolfe Research Sarah James - Cantor Fitzgerald Joshua Raskin - Nephron Research A.J. Rice - UBS Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Erin Wright - Morgan Stanley Scott Fidel - Stephens George Hill - Deutsche Bank Ryan Langston - TD Cowen Andrew Mok - Barclays Operator Good day, and thank you for standing by.
Humana (HUM) shares slid after the health insurer said it expects Medicare Advantage memberships to decline in 2025.
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
SAN DIEGO , Feb. 11, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of Humana Inc. (NYSE: HUM). Investors who purchased shares of Humana Inc. (NYSE: HUM) prior to July 2022 and continue to hold any of those NYSE: HUM shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.